Jessica Ritsick will lead the March 24 pre-conference session “Medical Devices, Combination Products, and Companion Diagnostics: The 2026 Playbook” at this event hosted by the American Conference Institute.
As the importance of AI and diagnostics continues to grow, medical devices become more complex, and FDA policies evolve, regulatory missteps can create late surprises and require costly fixes. This workshop provides a practical regulatory playbook addressing key FDA developments, common questions, and potential pitfalls to help keep teams aligned and timelines intact.